Bemarituzumab is a humanized IgG1 monoclonal antibody designed to selectively target and inhibit FGFR2b (fibroblast growth factor receptor 2b). By blocking the binding and activation of fibroblast growth factors to FGFR2b, Bemarituzumab effectively impedes cellular processes that contribute to tumor growth and proliferation. This antibody has demonstrated significant antitumor activity in clinical studies, particularly in the context of gastric and breast cancers, making it a valuable tool for research in oncology and targeted therapy development.
Bemarituzumab is a humanized IgG1 monoclonal antibody designed to selectively target and inhibit FGFR2b (fibroblast growth factor receptor 2b). By blocking the binding and activation of fibroblast growth factors to FGFR2b, Bemarituzumab effectively impedes cellular processes that contribute to tumor growth and proliferation. This antibody has demonstrated significant antitumor activity in clinical studies, particularly in the context of gastric and breast cancers, making it a valuable tool for research in oncology and targeted therapy development.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
